Genes involved in regulating antimicrobial immunity and inflammation may modulate the risk of tissue scarring and fibrosis in chlamydial diseases such as trachoma. By use of a large case-control study of scarring trachoma in The Gambia, the importance of single-nucleotide polymorphisms in several candidate genes was investigated. Overall, no significant differences were found between patients and control subjects in genotype frequencies for polymorphisms in cytokine promoters interleukin ( ). This single association is consistent with data indicating that the IL-10-P p .009 1082G allele is associated with higher levels of IL-10 transcription and that Th2-type immune responses are associated with risk of chlamydial disease.
Th2 responses may increase the risk of scarring trachoma in humans [3, 4] . The proinflammatory cytokine tumor necrosis factor (TNF)-a is involved in fibrogenesis and is associated with scarring trachoma [5, 6] . The mannose-binding protein (MBP), which is synthesized by hepatocytes and secreted into circulating serum, plays an important role in innate immunity by activating the classical complement pathway and by acting directly as an opsonin on pathogens rich in surface mannose. MBP binds to the chlamydial major outer-membrane protein and inhibits cellular infection by C. trachomatis in vitro [7] .
The human genes responsible-IL-10, IL-4, TNF-a, and MBP-contain single nucleotide polymorphisms (SNPs), which may potentially be associated with risk of trachomatous scarring. Three polymorphisms in the IL-10 promoter have been described (at positions -1082, -819, and -592), of which the -1082G allele is associated with higher levels of IL-10 production by lymphocytes [8] , and thus is a candidate allele for risk of trachoma [2] [3] [4] . A polymorphism at position -590 in the IL-4 promoter was suggested as being associated with different levels of IL-4 activity [9] and might also be important in trachoma. Several SNPs have been described in the TNF-a promoter, and the rarer allele at position -308 has been associated with increased transcription in some reporter gene assays [10] . This allele is associated with increased risk of scarring trachoma [6] . This association was not due to linkage disequilibrium of this allele with HLA genes and was independent of a separate disease association with an HLA class I allele [11] . A newly described TNF-a-376 polymorphism is associated with variation in TNF-a basal expression by monocytes [12] . Three polymorphisms have been found in the MBP gene [13] ; rarer alleles at 2 sites (codons 52 and 54) are virtually absent in an African population [13, 14] . The MBP codon 57 (glu) allele, common among Africans, is strongly related to a reduction of MBP level in serum [13] , and this may be predicted to cause lower resistance to C. trachomatis infection. In this study, we investigated whether these candidate IL-10, IL-4, TNF-a, and MBP polymorphisms are associated with risk of scarring trachoma in C. trachomatis-endemic populations in The Gambia.
Materials and Methods
Case-control study and sample collection. In total, 238 patients with obvious scarring of the subtarsal conjunctiva due to trachoma were recruited (trachomatous scarring, according to the simplified World Health Organization criteria). Of these, 185 also had trichiasis. These patients were identified from records of eyelid surgery at Kau-ur Health Centre, Central River Division, and Sibanor Mission Hospital, Western Division, The Gambia, and by surveying inhabitants of trachoma-endemic villages in The Gambia. The disease status was identified by ocular examination. Of the patients, 165 (69%) were female and mean age was 43 years (range, 6-75). The ethnic groups were Wolof (45%), Mandinka (24%), Jola (19%), Manjago (7%), and other (5%). We recruited 239 control subjects with normal eyelids with an aim to match for age, sex, and village of residence. The recruited control subjects were closely balanced with case patients by age, sex, and ethnic group (table 1) . From each subject, a 10-mL sample of venous blood was collected into heparin. Peripheral blood mononuclear cells were separated using ficoll-hypaque, and DNA was extracted. All 477 samples were typed for IL-10, IL-4, and TNF-a, and 343 samples were typed for MBP polymorphism.
Polymerase chain reaction (PCR) of IL-10, IL-4, TNF-a, and MBP fragments. PCR reactions were performed using ∼10 ng of each DNA sample, 50 mM KCl, 10 mM Tris-HCl, 0.1% Triton X-100, 2.5 mM MgCl 2 , 200 mM of each dATP, dGTP, dTTP, dCTP, 0.5 mM of each primer, and 1 U of Taq with a total volume of 10 mL. The methods used for individual genes are as follows. For IL-10, DNA was heated to 95ЊC for 3 min, followed by 40 cycles at 95ЊC for 30 s, 56ЊC for 30 s, and 72ЊC for 1 min using the primers described by Turner et al. [8] . For IL-4 and MBP, DNA was heated to 95ЊC for 3 min, followed by 30 cycles of 95ЊC for 30 s, 57ЊC for 30 s, and 72ЊC for 1 min. The IL-4 primers amplified nucleotides Ϫ680 to Ϫ491: forward, 5 -GTAAGGACCTTATGGACCTGC-3 ; reverse, 5 -CATCTTGGAAACTGTCCTGTC-3 . The MBP primers amplified nucleotides ϩ45 to ϩ236: forward, 5 -GCAGCG-TCTTACTCAGAAACT-3 ; reverse, 5 -TCCTCATATCCCCA-GGCA GT-3 . For TNF-a, DNA was heated to 95ЊC for 3 min, followed by 35 cycles at 95ЊC for 1 min, 60ЊC for 1 min, and 72ЊC for 1 min, using primers described by McGuire et al. [15] .
IL-10, IL-4, TNF-a, and MBP allele-specific oligonucleotide probing. PCR products were denatured for 2 min at 94ЊC, and 1.5 mL aliquots were dotted onto replicate nylon membranes in 96-dot arrays. Genotyping was performed using sequence-specific oligonucleotide probing. Eighteen-mer oligonucleotide probes were de- Statistical methods. To determine the significance of differences in proportions of genotypes between groups, x 2 or Fisher's exact tests were used on contingency tables. The magnitude of associations between disease status and genotypes was calculated as odds ratios (ORs) with 95% confidence intervals (CIs) with Epi-Info version 6.0 software (Centers for Disease Control and Prevention, Atlanta).
Results
IL-10-1082, -819, -592 polymorphisms. The 3 IL-10 promoter polymorphisms described elsewhere among Caucasians were observed in the Gambian population. Overall, there were no significant differences between patients and control subjects in genotype or allele frequencies for any of the 3 polymorphic sites (table 2). (Overall frequencies of rarer alleles were -1082G, 0.33; -819T, 0.48; -592A, 0.48.) In a comparison of frequencies among the ethnic groups, Mandinkas had highest IL-10-1082G allele frequency (0.36). Within the Mandinka group alone, the IL-10-1082G homozygote genotype was significantly more common among case patients (22%; 13 of 58) than among control subjects (5%; 3 of 56) (OR, 5.10; 95% CI, 1.24-24.2; ), but an association was not seen in the other ethnic P p .009 groups. In Mandinkas, the disease association was similar when the trichiasis case patients (OR, 5.48;
) and the case P p .012 patients with scarring only, but not trichiasis, were considered separately (OR, 4.42;
). P p .07 IL-4-590 polymorphism. There were no significant differences observed in the proportions of the IL-4-590 genotypes between case patients and control subjects (table 2) or in the allele frequencies (overall frequency of the rarer allele -590C, 0.29). The 4 ethnic groups showed similar allele frequencies, and no significant differences in frequencies were observed between case patients and control subjects within each ethnic group.
TNF-376 polymorphism. The rare TNF-376A allele was found at an allele frequency of 0.03 (no rare homozygotes were seen). Overall genotype frequencies did not differ between patients and control subjects (table 2), and allele frequencies were similar among the ethnic groups.
MBP polymorphism. In all, 179 case patients and 164 control subjects were tested for the MBP codon 57 (Gly/Glu) polymorphism. Proportions of genotypes were very similar among case patients and control subjects (no significant difference, ): 57Gly homozygote, 54.2% of case patients and 52.5% P p .80 of control subjects; 57Gly/Glu heterozygote, 39.7% of case patients and 39.6% of control subjects; and 57Glu homozygote, 6.1% of case patients and 7.9% of control subjects. Allele frequencies did not differ significantly among ethnic groups (overall frequency of rarer allele 57Glu, 0.27).
Discussion
Several human gene polymorphisms, with strong candidacy for involvement in processes of inflammation and immunity in trachoma, were tested for association with conjunctival scarring. Scarring trachoma was previously associated with the TNF-a-308A allele (and with a trend toward association with the TNF-a-238A allele) [6] , so the newly described polymorphism TNF-a-376A [12] was tested. No TNF-a-376A homozygotes were seen, but heterozygotes were present in about 5% of both case patients and control subjects, so the TNF-a-376A allele appears not to be associated with the development of scarring trachoma.
Three polymorphisms in the IL-10 promoter gene, described elsewhere among Caucasians [8] , were also seen in the Gambian population. However, the allele frequencies of these populations differ, with lower frequencies of -1082G, -819C, and -592C alleles among Gambians (respectively, 0.33, 0.52, and 0.52), compared with whites (respectively, 0.51, 0.79, and 0.79). There was a significant disease association for IL-10-1082G homozygotes, but only within 1 ethnic group (Mandinkas). This association is concordant with the hypothesis that a higher IL-10 expression is involved in the susceptibility to chlamydial infection and disease [2] [3] [4] and with data indicating that the IL-10-1082G allele is associated with higher IL-10 production [8] . However, as the significant association was only detected within 1 ethnic group, the possibility of a chance association cannot be excluded.
The IL-4-590 promoter polymorphism, described originally in a Jewish population, is present among Gambians. The IL-4-590T is associated with higher levels of serum IgE and higher transcription of a reporter gene [9] . Among American Jews, the IL-4-590T was found in 35 (37%) of 95 patients examined, but precise allele frequencies were not specified [9] . In the present study, the IL-4-590T allele had an overall frequency of 0.71, indicating that this allele is much more common in Gambians than in a Jewish population. No significant frequency difference was found between case patients and the control subjects for the genotypes of IL-4-590, indicating that, even if this allele is related to higher IL-4 activity and production, it is not associated with risk of scarring trachoma.
Previous studies demonstrated the presence of the MBP codon 57 polymorphism among Gambians [13, 14] , and the MBP57Glu allele frequency of 0.27 observed here is similar to that reported. The genotype frequencies did not differ between trachoma patients and control subjects, so although the MBP57Glu allele is strongly related to lower MBP serum levels in vivo [13] , it is probably not associated with lower resistance to C. trachomatis infection which would increase the risk of scarring trachoma. Of note, MBP can bind C. trachomatis only during its brief extracellular stage, and serum concentrations may not be sufficient to reduce the intensity of infection in vivo, even though an inhibitory effect was observed at higher concentrations in vitro [7] .
The general lack of association between these candidate gene polymorphisms and trachomatous scarring, with the exception of a single association for IL10-1082, does not necessarily imply that the proteins encoded are not important in mechanisms of protection or pathology but indicates that variation among persons in their risk of disease is not explained by these polymorphisms. Extensive studies of the genetics of susceptibility to human chlamydial diseases are required to quantify the heritability of risk of disease and to identify new candidate genes.
